Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Martin Erik Nyeland"'
Autor:
Espen Jimenez-Solem, Tonny S. Petersen, Casper Hansen, Christian Hansen, Christina Lioma, Christian Igel, Wouter Boomsma, Oswin Krause, Stephan Lorenzen, Raghavendra Selvan, Janne Petersen, Martin Erik Nyeland, Mikkel Zöllner Ankarfeldt, Gert Mehl Virenfeldt, Matilde Winther-Jensen, Allan Linneberg, Mostafa Mehdipour Ghazi, Nicki Detlefsen, Andreas David Lauritzen, Abraham George Smith, Marleen de Bruijne, Bulat Ibragimov, Jens Petersen, Martin Lillholm, Jon Middleton, Stine Hasling Mogensen, Hans-Christian Thorsen-Meyer, Anders Perner, Marie Helleberg, Benjamin Skov Kaas-Hansen, Mikkel Bonde, Alexander Bonde, Akshay Pai, Mads Nielsen, Martin Sillesen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Patients with severe COVID-19 have overwhelmed healthcare systems worldwide. We hypothesized that machine learning (ML) models could be used to predict risks at different stages of management and thereby provide insights into drivers and pro
Externí odkaz:
https://doaj.org/article/aa3f45fd445f4117b36899935a16679d
Autor:
Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, Tonny Studsgaard Petersen
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-3 (2020)
Externí odkaz:
https://doaj.org/article/c56f3a9c3621449c8f160feafb2e9b5e
Autor:
Ronan M. G. Berg, Andreas Ronit, Nicolai Haase, Morten Hylander Møller, Klaus T. Kristiansen, Trine Jonassen, Christian Wamberg, Anne Sofie Andreasen, Thomas Mohr, Morten H. Bestle, Vibeke L. Jørgensen, Niels R. Hammer, Anja U. Mitchell, Margit Smitt, Anders Møller Greve, Martin Erik Nyeland, Britt Wang Jensen, Anne Helms Andreasen, Janne Petersen, Espen Jimenez Solem, Matilde Winther‐Jensen, Ronni R. Plovsing
Publikováno v:
Acta Anaesthesiologica Scandinavica.
Autor:
Martin Erik Nyeland, Astrid Blicher Schelde, Espen Jimenez-Solem, Anne Mette Skov Sørensen, Hans Kristian Råket Pedersen
Publikováno v:
Adverse Drug Reaction Bulletin.
Autor:
Anne Helms Andreasen, Matilde Tejlbo Frost, Martin Erik Nyeland, Espen Jimenez-Solem, Tonny Studsgaard Petersen, Mikkel Zöllner Ankarfeldt
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-3 (2020)
Frost, M T, Jimenez-Solem, E, Ankarfeldt, M Z, Nyeland, M E, Andreasen, A H & Petersen, T S 2020, ' The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population : a comparative observational study ', Critical Care, vol. 24, no. 1, 677 . https://doi.org/10.1186/s13054-020-03406-3
Frost, M T, Jimenez-Solem, E, Ankarfeldt, M Z, Nyeland, M E, Andreasen, A H & Petersen, T S 2020, ' The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population : a comparative observational study ', Critical Care, vol. 24, no. 1, 677 . https://doi.org/10.1186/s13054-020-03406-3
Autor:
Søren Overgaard, Astrid Blicher Schelde, Martin Erik Nyeland, Anne Mette Skov Sørensen, Espen Jimenez-Solem, Anders Odgaard
Publikováno v:
Sørensen, A M S, Nyeland, M E, Odgaard, A, Overgaard, S, Jimenez-Solem, E & Schelde, A B 2021, ' Drug-related challenges following primary total hip and knee arthroplasty ', Basic and Clinical Pharmacology and Toxicology, vol. 129, no. 2, pp. 139-147 . https://doi.org/10.1111/bcpt.13616
Sørensen, A M S, Nyeland, M E, Odgaard, A, Overgaard, S, Jimenez-Solem, E & Schelde, A B 2021, ' Drug-related challenges following primary total hip and knee arthroplasty ', Basic & Clinical Pharmacology & Toxicology, vol. 129, no. 2, pp. 139-147 . https://doi.org/10.1111/bcpt.13616
Sørensen, A M S, Nyeland, M E, Odgaard, A, Overgaard, S, Jimenez-Solem, E & Schelde, A B 2021, ' Drug-related challenges following primary total hip and knee arthroplasty ', Basic & Clinical Pharmacology & Toxicology, vol. 129, no. 2, pp. 139-147 . https://doi.org/10.1111/bcpt.13616
We aimed to characterize the in-hospital analgesic use among total hip or knee arthroplasty (THA or TKA) patients, and to identify possible drug-related challenges. We identified 15 263 patients operated with a THA or TKA between 1 January 2012 and 3
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:607-614
Purpose For both marketing authorization holders and regulatory authorities, evaluating the effectiveness of risk minimization measures is now an integral part of pharmacovigilance in the European Union. The overall aim of activities in this area is
Publikováno v:
Primary care diabetes. 14(4)
Aims This retrospective, longitudinal study characterised 2430 adults (mean age 40.8 ± 16.1 years) with newly diagnosed type 1 diabetes (T1D) over the first 5 years of insulin treatment. Methods Data from 1 year pre- and up to 5 years post-insulin i
Publikováno v:
Pharmacoepidemiology and drug safety. 26(6)
For both marketing authorization holders and regulatory authorities, evaluating the effectiveness of risk minimization measures is now an integral part of pharmacovigilance in the European Union. The overall aim of activities in this area is to asses